1106
Ebenryter et al.:
N-Glycoside 7: RF 0.11 CHCl3–MeOH 98:2; 0.51 CH3COOC2H5. 1H NMR (250 MHz,
CDCl3): 8.46 dd, 1 H, 3J(5,4) = 4.0, 4J(6,4) = 2.3 (H4); 8.42 dd, 1 H, 3J(6,5) = 6.7, 4J(6,4) = 2.3
(H6); 7.82–8.09 m, 6 H (Ar-H); 7.26–7.68 m, 9 H (Ar-H); 7.03 d, 1 H, 3J(1′,2′) = 2.0 (H1′);
6.46 dd, 1 H, 3J(5,4) = 4.0, 3J(5,6) = 6.7 (H5); 6.01 dd, 1 H, 3J(2′,1′) = 2.0, 3J(2′,3′) = 5.0 (H2′);
5.77 dd, 1 H, 3J(3′,2′) = 5.0, 3J(3′,4′) = 7.8 (H3′); 4.87–4.97 m, 2 H (H4′,H5′); 4.65–4.72 m, 1
H (H5′′).
S-Glycoside 8: RF 0.47 CHCl3–MeOH 98:2; 0.64 CH3COOC2H5. 1H NMR (250 MHz, CDCl3):
8.56 d, 2 H, 3J(6,5) = 3J(4,5) = 4.9 (H4, H6); 7.30–8.13 m, 15 H (Ar-H); 7.03 t, 1 H, 3J(5,6) =
3J(5,4) = 4.9 (H5); 6.51 d, 1 H, 3J(1′,2′) = 3.8 (H1′); 6.04 dd, 1 H, 3J(2′,3′) = 5.0, 3J(2′,1′) = 3.8
(H2′); 5.96 dd, 1 H, 3J(3′,2′) = 5.0, 3J(3′,4′) = 5.9 (H-3′); 4.80 m, 1 H (H4′); 4.71 dd, 1 H,
2J(5′,5′′) = 12.1, 3J(5′,4′) = 4.0 (H5′); 4.60 dd, 1 H, 2J(5′′,5′) = 12.1, 3J(5′′,4′) = 4.1 (H5′′).
1-(β-D-Ribofuranosyl)-1,2-dihydropyrimidine-2-thione (s2zeb, 1)
The benzoylated derivative 7 (800 mg, 1.44 mmol) was suspended in anhydrous MeOH
(57 ml), slightly warmed and then the solution was allowed to cool down to the room tem-
perature. Afterwards 1 M solution of MeONa in MeOH was added (1.4 ml). The mixture was
stirred at room temperature for 30 min. After this time TLC analysis (15% MeOH in CHCl3)
showed that the starting material was completely consumed. The mixture was worked up
with Dowex (pyridine salt form) and after filtered off the resin, the remaining solution was
evaporated in vacuo and coevaporated with toluene. The oily residue was dissolved in water
(15 ml) and washed with diethyl ether (3 × 10 ml). The aqueous layer was frozen and
lyophilized to give N-glycoside 1 (0.25 g, 1.02 mmol; yield 71%). 1H NMR (700 MHz, D2O):
8.82 dd, 1 H, 3J(6,5) = 6.8, 4J(6,4) = 2.2 (H6); 8.49 dd, 1 H, 3J(5,4) = 4.4, 4J(6,4) = 2.2 (H4);
7.09 dd, 1 H, 3J(5,4) = 4.4, 3J(5,6) = 6.8 (H5); 6.38 s, 1 H (H1′); 4.37 d, 1 H, 3J(2′,3′) = 4.9
(H2′); 4.22 ddd, 1 H, 3J(4′,5′) = 2.4, 3J(4′,5′) = 3.5, 3J(4′,3′) = 9.4 (H4′); 4.10 dd, 1 H, 3J(3′,2′) =
4.9, 3J(3′,4′) = 9.4 (H3′); 4.05 dd, 1 H, 3J(4′,5′) = 2.4, 2J(5′,5′′) = 13.2 (H5′); 3.85 dd, 1 H,
3J(4′,5′) = 3.5, 2J(5′,5′′) = 13.2 (H5′′). 13C NMR (175 MHz, D2O): 179.76 (C2), 160.24 (C4),
145.69 (C6), 111.50 (C5), 95.93 (C1′), 83.55 (C4′), 74.54 (C2′), 67.26 (C3′), 59.23 (C5′).
MS-FAB (m/z, %): 245.1 (100) [M + H]+, calculated for C9H12O4N2S: 244. UV-Spectrum
(H2O): λmax 281 nm (ε 15739), 216 nm (ε 6630), 351 nm (ε 2662).
2S-(β-D-Ribofuranosyl)-2-thiopyrimidine (9)
The benzoylated derivative 8 (100 mg, 0.18 mmol) was dissolved in saturated methanolic
ammonia (10 ml) and the mixture was stirred at room temperature for 48 h. After this time
the reaction was judged to be complete by TLC (20% MeOH in CHCl3) and the mixture was
evaporated in vacuo. The residue was dissolved in water (10 ml) and washed with diethyl
ether (3 × 10 ml) to remove the methyl benzoate and benzamide. The crude product was pu-
rified by silica gel column chromatography (CHCl3/MeOH gradient from 100 to 90%). The
fraction containing product was evaporated, dissolved in water, frozen and lyophilized to
give S-glycoside 9 (36 mg, 0.15 mmol; 82%). 1H NMR (250 MHz, D2O): 8.55 d, 2 H, 3J(4,5) =
3J(6,5) = 4.9 (H4, H6); 7.23 t, 1 H, 3J(5,6) = 3J(5,4) = 4.9 (H5); 5.89 d, 1 H, 3J(1′,2′) = 5.0
(H1′); 4.20–4.31 m, 2 H, 3J(3′,4′) = 9.4, 3J(2′,1′) = 5.0 (H3′, H2′); 4.02–4.08 m, 1 H, 3J(4′,5′) =
3.7, 3J(4′,5′′) = 4.9, 3J(4′,3′) = 9.4 (H4′); 3.70 dd, 1 H, 2J(5′,5′′) = 12.5, 3J(5′,4′) = 3.7 (H5′);
3.61 dd, 1 H, 2J(5′,5′′) = 12.5, 3J(5′′,4′) = 4.9 (H5′′). 13C NMR (62 MHz, D2O): 168.91 (C2),
158.15 (C6, C4), 118.32 (C5), 86.29 (C1′), 85.05 (C4′), 74.43 (C2′), 70.74 (C3′), 61.44 (C5′).
Collect. Czech. Chem. Commun. 2011, Vol. 76, No. 9, pp. 1103–1119